Esopra 20 mg (Capsule (Enteric Coated))
Unit Price: ৳ 6.02 (6 x 10: ৳ 361.20)
Strip Price: ৳ 60.20
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | Alco pharma ltd |
Also available as |
Title
Esopra 20 mg Capsule
Categories
- Medication
- Pharmaceutical
- Gastrointestinal
Description
A proton pump inhibitor (PPI) used to treat chronic heartburn (GERD), erosive esophagitis, Helicobacter pylori infection, Zollinger-Ellison Syndrome, and other acid-related dyspepsia. Available in oral dosage forms and IV injection, Esopra has specific indications, dosage recommendations, administration guidelines, and potential drug interactions.
Attributes
- Dosage Forms:
- Oral capsule
- Oral suspension
- IV injection
- Indications:
- Relief of chronic heartburn symptoms
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection
- Treatment for Zollinger-Ellison Syndrome
- Symptomatic GERD relief
- Duodenal ulcer and gastric ulcer treatment
- Mode of Action:
- Proton pump inhibitor
- Suppression of gastric acid secretion
- Specific inhibition of H+/K+-ATPase
- Single optical isomer of proton pump inhibitor
- Pharmacokinetics:
- Absorption through enteric-coated pellets
- Peak plasma levels at approximately 1.5 hours
- Metabolism through CYP2C19 and CYP3A4
- Excretion via urine and faeces
- Increased bioavailability during triple therapy
- Interaction:
- Metabolism by CYP2C19 and CYP3A4
- Potential interference with CYP2C19 substrates
- Inhibition of gastric acid secretion affecting drug absorption
- Contraindications:
- Known hypersensitivity to the formulation
- Side Effects:
- Headache
- Diarrhea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
- Pregnancy & Lactation:
- No adequate and well-controlled studies in pregnant women
- No teratogenic effects in animal studies
- Excretion in milk not studied
- Discontinuation of breastfeeding if essential
- Precautions & Warnings:
- Symptomatic response does not exclude gastric malignancy
- Guidelines for patients with difficulty swallowing capsules
- Use of antacids during treatment
- Special Populations:
- Pediatric use not established
- No significant differences observed in geriatric use
- No dosage adjustment in mild to moderate hepatic insufficiency
- Expected unchanged pharmacokinetics in renal impairment
- Overdose Effects:
- Lethal in rats at high doses
- No specific antidote known
- Symptomatic and supportive treatment recommended
- Storage Conditions:
- Store at a temperature not exceeding 30°C
- Protect from light and moisture
- Keep out of reach of children
- Chemical Structure:
- Molecular formula: C17H19N3O3S
- Chemical structure image available
- Commonly Asked Questions:
- Uses of Esopra 20 mg Capsule
- Side effects and pregnancy/lactation considerations
- Onset of action and quick tips for usage
Related Brands
- Esopra 40 mg (Capsule (Enteric Coated)) - alco-pharma-ltd
- Nuloc 20 mg (Tablet (Enteric Coated)) - monicopharma-ltd
- Asector 40 mg/vial (IV Injection) - novo-healthcare-and-pharma-ltd
- Esomium 40 mg (Capsule (Enteric Coated)) - jenphar-bangladesh-ltd
- Esozyme 20 mg (Capsule (Enteric Coated)) - cosmic-pharma-ltd